Reirradiation in recurrent glioblastoma
Reirradiation is gaining acceptance as a palliative yet potentially impactful treatment for recurrent glioblastoma. While current evidence supports its use in selected cases, results from ongoing phase III LEGATO trial will determine its future role in standard care and inform evidence-based clinical decision-making.
Authors
- Lucie Hnidáková
- Tomáš Kazda (ORCID: https://orcid.org/0000-0001-7288-8975)
- Giuseppe Minniti (ORCID: https://orcid.org/0000-0003-1239-1603)
Institutions
- Masaryk University (CZ)
- Policlinico Umberto I (IT)
- Masaryk Memorial Cancer Institute (CZ)
Publication Details
- Journal
- Current Opinion in Oncology
- Published
- 2025-09-03
- DOI
- https://doi.org/10.1097/cco.0000000000001192
- Primary Topic
- Glioma Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00